The value and limitations of long-term nucleoside antiviral therapy in chronic hepatitis B

被引：5
|
作者：
Dienstag, JL
机构：
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit,Med Serv, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA
来源：
JOURNAL OF HEPATOLOGY | 2005年 / 42卷 / 02期
关键词：
D O I：
10.1016/j.jhep.2004.12.001
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：158 / 162
页数：5
相关论文
共 50 条
  • [1] Predictive Value of hepatitis B Virus Genotypes on the Responses to Long-term Nucleoside Analogue Therapy in Patients with Chronic Hepatitis B
    Watanabe, Hisayoshi
    Sato, Chikako
    Mizuno, Kei
    Katsumi, Tomohiro
    Tomita, Kyoko
    Okumoto, Kazuo
    Nishise, Yuko
    Saito, Takafumi
    Kawata, Sumio
    Ueno, Yoshiyuki
    HEPATOLOGY, 2013, 58 : 691A - 691A
  • [2] LONG-TERM RESULTS OF ANTIVIRAL THERAPY IN CHRONIC TYPE-B HEPATITIS
    GIULIANIPICCARI, G
    FORMICA, G
    SARTI, F
    SPONGANO, P
    DALMONTE, PR
    JOURNAL OF MEDICAL VIROLOGY, 1987, 21 (04) : A130 - A130
  • [3] Long-term therapy with nucleoside/nucleotide analogues for chronic hepatitis B in Asian patients
    Pan, Calvin Q.
    Hu, Ke-Qin
    Tsai, Naoky
    ANTIVIRAL THERAPY, 2013, 18 (07) : 841 - 852
  • [4] Therapy for chronic Hepatitis B: Antiviral long-term therapy with Entacavir leads to decline of liver fibrosis in a case of chronic Hepatitis B
    不详
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2009, 47 (03): : B2 - B4
  • [5] ANTIVIRAL THERAPY FOR THE PREVENTION OF LONG-TERM CIRRHOSIS RISK IN PATIENTS WITH CHRONIC HEPATITIS B
    Yang, H. -I.
    Hoang, J.
    Lin, D.
    Liu, J.
    Hu, H. -H.
    Lee, M. -H.
    Nguyen, N. H.
    Kim, Y.
    Jen, C. -L.
    Vu, V.
    Le, A.
    Chaung, K.
    Nguyen, V.
    Trinh, H.
    Li, J.
    Zhang, J.
    Hsing, A.
    Chen, C. -J.
    Nguyen, M. H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S591 - S591
  • [6] Disease Progression in Chronic Hepatitis B Patients under Long-Term Antiviral Therapy
    Moon, Jin Chang
    Kim, Seong Hun
    Kim, In Hee
    Lee, Chang Hun
    Kim, Sang Wook
    Lee, Seung Ok
    Lee, Soo Teik
    Kim, Dae-Ghon
    GUT AND LIVER, 2015, 9 (03) : 395 - 404
  • [7] Potential Impact of Long-Term Nucleoside Therapy on the Mortality and Morbidity of Active Chronic Hepatitis B
    Toy, Mehlika
    Veldhuijzen, Irene K.
    de Man, Robert A.
    Richardus, Jan Hendrik
    Schalm, Solko W.
    HEPATOLOGY, 2009, 50 (03) : 743 - 751
  • [8] Entecavir: a potent antiviral with minimal long-term resistance in nucleoside-naive chronic hepatitis B patients
    Cheng, Pin-Nan
    Chang, Ting-Tsung
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2008, 6 (05) : 569 - 579
  • [9] Improved outcome of chronic hepatitis B after heart transplantation by long-term antiviral therapy
    Potthoff, A.
    Tillmann, H. L.
    Bara, C.
    Deterding, K.
    Pethig, K.
    Meyer, S.
    Haverich, A.
    Boeker, K. H. W.
    Manns, M. P.
    Wedemeyer, H.
    JOURNAL OF VIRAL HEPATITIS, 2006, 13 (11) : 734 - 741
  • [10] RISK ASSESSMENT OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS WITH LONG-TERM ANTIVIRAL THERAPY
    Chung, K. S.
    Lee, H. W.
    Kim, D. Y.
    Kim, B. K.
    Kim, S. U.
    Park, J. Y.
    Han, K. -H.
    Ahn, S. H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S517 - S517
12345